Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 704289, 8 pages
http://dx.doi.org/10.1155/2014/704289
Clinical Study

Long-Term Effects and Prognosis in Acute Heart Failure Treated with Tolvaptan: The AVCMA Trial

1Department of Cardiology and Hematology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan
2Department of Cardiology, Ohara Medical Center, Fukushima 960-0195, Japan
3Second Department of Medicine, Shirakawa Kosei General Hospital, Shirakawa 961-0005, Japan
4Department of Cardiology, Fukushima Red Cross Hospital, Fukushima 960-8530, Japan
5First Department of Internal Medicine, Yamagata University School of Medicine, Yamagata 990-9585, Japan

Received 13 May 2014; Revised 28 August 2014; Accepted 8 September 2014; Published 10 November 2014

Academic Editor: James Kirkpatrick

Copyright © 2014 Satoshi Suzuki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Satoshi Suzuki, Akiomi Yoshihisa, Takayoshi Yamaki, et al., “Long-Term Effects and Prognosis in Acute Heart Failure Treated with Tolvaptan: The AVCMA Trial,” BioMed Research International, vol. 2014, Article ID 704289, 8 pages, 2014. https://doi.org/10.1155/2014/704289.